Identification of hepatic NPC1L1 as an NAFLD risk factor evidenced by ezetimibe‐mediated steatosis prevention and recovery.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 5, p. 283, doi. 10.1096/fba.2018-00044
- By:
- Publication type:
- Article
Works matching IS 25739832 AND DT 2019 AND VI 1 AND IP 5
Results: 6
1
2
Issue Information.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 5, p. 279, doi. 10.1096/fba.1053
- Publication type:
- Article
3
Bile acid receptor agonists in primary biliary cholangitis: Regulation of the cholangiocyte secretome and downstream T cell differentiation.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 5, p. 332, doi. 10.1096/fba.2018-00046
- By:
- Publication type:
- Article
4
Phytohormone metabolism in human cells: Cytokinins are taken up and interconverted in HeLa cell culture.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 5, p. 320, doi. 10.1096/fba.2018-00032
- By:
- Publication type:
- Article
5
Glutathione increase by the n‐butanoyl glutathione derivative (GSH‐C4) inhibits viral replication and induces a predominant Th1 immune profile in old mice infected with influenza virus.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 5, p. 296, doi. 10.1096/fba.2018-00066
- By:
- Publication type:
- Article
6
A novel mutation alters the stability of PapA2 resulting in the complete abrogation of sulfolipids in clinical mycobacterial strains.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 5, p. 306, doi. 10.1096/fba.2018-00039
- By:
- Publication type:
- Article